Assessment of cardiac iron deposition in sickle cell disease using 3.0 tesla cardiovascular magnetic resonance

Hemoglobin

Volumn 36, Issue 4, 2012, Pages 343-361

  Ibrahim, El Sayed H ^a   Rana, Fauzia N ^a   Johnson, Kevin R ^a   White, Richard D ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

3.0 Tesla; Cardiac iron overload; Cardiovascular magnetic resonance (CMR); Sickle cell disease

Indexed keywords

FERRITIN; IRON;

ADULT; ARTICLE; BLOOD TRANSFUSION; CARDIOVASCULAR MAGNETIC RESONANCE; CARDIOVASCULAR RISK; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FERRITIN BLOOD LEVEL; HEART MUSCLE; HUMAN; IMAGING SYSTEM; INTERMETHOD COMPARISON; IRON OVERLOAD; LIVER; MALE; PHANTOM; SENSITIVITY ANALYSIS; SICKLE CELL ANEMIA; THALASSEMIA;

ADULT; ANEMIA, SICKLE CELL; BLOOD TRANSFUSION; FEMALE; FERRITINS; HUMANS; IRON; IRON OVERLOAD; MAGNETIC RESONANCE IMAGING; MALE; MYOCARDIUM; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 84862875460     PISSN: 03630269     EISSN: 1532432X     Source Type: Journal    
DOI: 10.3109/03630269.2012.679376     Document Type: Article

References (41)

1. Platt OS, Brambilla DJ, Rosse WF, et al. Mortality in sickle cell disease. Life expectancy and risk factors for early death. N Engl J Med. 1994;330(23):1639-1644.
2. Bunn HF. Pathogenesis and treatment of sickle cell disease. N Engl J Med. 1997;337(11):762-769.
3. Wahl S, Quirolo KC. Current issues in blood transfusion for sickle cell disease. Curr Opin Pediatr. 2009;21(1):15-21.
4. Harmatz P, Butensky E, Quirolo K, et al. Severity of iron overload in patients with sickle cell disease receiving chronic red blood cell transfusion therapy. Blood. 2000;96(1):76-79.
5. McLaren GD, Muir WA, Kellermeyer RW. Iron overload disorders: natural history, pathogenesis, diagnosis, and therapy. Crit Rev Clin Lab Sci. 1983;19(3):205-266.
6. Porter JB. Concepts and goals in the management of transfusional iron overload. Am J Hematol. 2007;82(12 Suppl.):1136-1139.
7. Wacker P, Halperin DS, Balmer-Ruedin D, Oberhansli I, Wyss M. Regression of cardiac insufficiency after ambulatory intravenous deferoxamine in thalassemia major. Chest. 1993;103(4):1276-1278.
8. Patton N, Brown G, Leung M, et al. Observational study of iron overload as assessed by magnetic resonance imaging in an adult population of transfusion-dependent patients with β thalassaemia: significant association between low cardiac T2* <10 ms and cardiac events. Intern Med J. 2010;40 (6):419-426.
9. Kolnagou A, Economides C, Eracleous E, Kontoghiorghes GJ. Low serum ferritin levels are misleading for detecting cardiac iron overload and increase the risk of cardiomyopathy in thalassemia patients. The importance of cardiac iron overload monitoring using magnetic resonance imaging T2 and T2*. Hemoglobin. 2006;30(2):219-227.
10. Frey WG, 3rd, Gardner MH, Pillsbury JA. Quantitative measurement of liver iron by needle biopsy. J Lab Clin Med. 1968;72(1):52-57.
11. Mavrogeni SI, Markussis V, Kaklamanis L, et al. A comparison of magnetic resonance imaging and cardiac biopsy in the evaluation of heart iron overload in patients with β-thalassemia major. Eur J Haematol. 2005;75(3):241-247.
12. Henry WL, Nienhuis AW, Wiener M, Miller DR, Canale VC, Piomelli S. Echocardiographic abnormalities in patients with transfusion-dependent anemia and secondary myocardial iron deposition. Am J Med. 1978;64(4):547-755.
13. Harada M, Hirai K, Sakisaka S, Ueno T, Abe H, Tanikawa K. Comparative study of magnetic resonance imaging, computed tomography and histology in the assessment of liver iron overload. Intern Med. 1992;31(2):180-184.
14. Vartsky D, Ellis KJ, Hull DM, Cohn SH. Nuclear resonant scattering of gamma rays -a new technique for in vivo measurement of body iron stores. Phys Med Biol. 1979;24(4):689-701.
15. Nielsen P, Engelhardt R, Duerken M, Janka GE, Fischer R. Using SQUID biomagnetic liver susceptometry in the treatment of thalassemia and other iron loading diseases. Transfus Sci. 2000;23 (3):257-258.
16. Voskaridou E, Douskou M, Terpos E, et al. Magnetic resonance imaging in the evaluation of iron overload in patients with β thalassaemia and sickle cell disease. Br J Haematol. 2004;126(5):736-742.
17. Wood JC, Enriquez C, Ghugre N, et al. MRI R2 and R2* mapping accurately estimates hepatic iron concentration in transfusion-dependent thalassemia and sickle cell disease patients. Blood. 2005;106 (4):1460-1465.
18. Wood JC. Magnetic resonance imaging measurement of iron overload. Curr Opin Hematol. 2007;14 (3):183-190.
19. Mavrogeni S. Evaluation of myocardial iron overload using magnetic resonance imaging. Blood Transfus. 2009;7(3):183-187.
20. Bondestam S, Lamminen A, Anttila VJ, Ruutu T, Ruutu P. Magnetic resonance imaging of transfusional hepatic iron overload. Br J Radiol. 1994;67(796):339-341.
21. Johnston DL, Rice L, VickGW3rd, Hedrick TD, Rokey R. Assessment of tissue iron overload by nuclear magnetic resonance imaging. Am J Med. 1989;87(1):40-47.
22. Anderson LJ, Holden S, Davis B, et al. Cardiovascular T2-star (T2*) magnetic resonance for the early diagnosis of myocardial iron overload. Eur Heart J. 2001;22(23):2171-2179.
23. Hankins JS, McCarville MB, Loeffler RB, et al. R2* magnetic resonance imaging of the liver in patients with iron overload. Blood. 2009;113(20):4853-4855.
24. Papakonstantinou OG, Maris TG, Kostaridou V, et al. Assessment of liver iron overload by T2-quantitative magnetic resonance imaging: correlation of T2-QMRI measurements with serum ferritin concentration and histologic grading of siderosis. Magn Reson Imaging. 1995;13(7):967-977.
25. Alexopoulou E, Stripeli F, Baras P, et al. R2 relaxometry with MRI for the quantification of tissue iron overload in beta-thalassemic patients. J Magn Reson Imaging. 2006;23(2):163-170.
26. Di Tucci AA, Matta G, Deplano S, et al. Myocardial iron overload assessment by T2* magnetic resonance imaging in adult transfusion dependent patients with acquired anemias. Haematologica. 2008;93(9):1385-1388.
27. Pennell DJ. T2* magnetic resonance and myocardial iron in thalassemia. Ann NY Acad Sci. 2005;1054:373-378.
28. Kondur AK, Li T, Vaitkevicius P, Afonso L. Quantification of myocardial iron overload by cardiovascular magnetic resonance imaging T2* and review of the literature. Clin Cardiol. 2009;32(6):E55-59.
29. Cheong B, Huber S, Muthupillai R, Flamm SD. Evaluation of myocardial iron overload by T2* cardiovascular magnetic resonance imaging. Tex Heart Inst J. 2005;32(3):448-449.
30. Fragasso A, Ciancio A, Mannarella C, et al. Myocardial iron overload assessed by magnetic resonance imaging (MRI)T2* in multi-transfused patients with thalassemia and acquired anemias. Eur J Intern Med. 2010;22(1):62-65.
31. Sakuta J, Ito Y, Kimura Y, Park J, Tokuuye K, Ohyashiki K. Estimation of cardiac left ventricular ejection fraction in transfusional cardiac iron overload by R2* magnetic resonance. Int J Hematol. 2010;92 (5):708-712.
32. Seldrum S, Pierard S, Moniotte S, et al. Iron overload in polytransfused patients without heart failure is associated with subclinical alterations of systolic left ventricular function using cardiovascular magnetic resonance tagging. J Cardiovasc Magn Reson. 2011;13:23.
33. Wood JC, Tyszka JM, Carson S, Nelson MD, Coates TD. Myocardial iron loading in transfusiondependent thalassemia and sickle cell disease. Blood. 2004;103(5):1934-1936.
34. Wood JC, Ghugre N. Magnetic resonance imaging assessment of excess iron in thalassemia, sickle cell disease and other iron overload diseases. Hemoglobin. 2008;32(1-2):85-96.
35. Raman SV, Simonetti OP, Cataland SR, Kraut EH. Myocardial ischemia and right ventricular dysfunction in adult patients with sickle cell disease. Haematologica. 2006;91(10):1329-1335.
36. Westwood MA, Shah F, Anderson LJ, et al. Myocardial tissue characterization and the role of chronic anemia in sickle cell cardiomyopathy. J Magn Reson Imaging. 2007;26(3):564-568.
37. Virtanen JM, Komu ME, Parkkola RK. Quantitative liver iron measurement by magnetic resonance imaging: in vitro and in vivo assessment of the liver to muscle signal intensity and the R2* methods. Magn Reson Imaging. 2008;26(8):1175-1182.
38. Ghugre NR, Enriquez CM, Coates TD, Nelson MD Jr, Wood JC. Improved R2* measurements in myocardial iron overload. J Magn Reson Imaging. 2006;23(1):9-16.
39. Storey P, Thompson AA, Carqueville CL, Wood JC, de Freitas RA, Rigsby CK. R2* imaging of transfusional iron burden at 3T and comparison with 1.5T. J Magn Reson Imaging. 2007;25(3):540-547.
40. Kolnagou A, Yazman D, Economides C, Eracleous E, Kontoghiorghes GJ. Uses and limitations of serum ferritin, magnetic resonance imaging T2 and T2* in the diagnosis of iron overload and in the ferrikinetics of normalization of the iron stores in thalassemia using the International Committee on Chelation deferiprone/deferoxamine combination protocol. Hemoglobin. 2009;33(5):312-322.
41. Mazza P, Giua R, De Marco S, et al. Iron overload in thalassemia: comparative analysis of magnetic resonance imaging, serum ferritin and iron content of the liver. Haematologica. 1995;80(5):398-404.